The same rational is true regarding the glucose uptake ability, since mTOR increases GLUT1 expression via HIF1α in some tumours [26], while AMPK pathway also leads to increased glucose uptake and hexokinase activity in normal thyrocytes [19]. The gene discussed is SLC2A1; the disease is neoplasm.